Bank Of Montreal Biotechnology

Bank Of Montreal

$192 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ADPT Adaptive Biotechnologies Corp	$1.3B	$237,000 0.0% of portfolio	31,908	Q1 2025 Added 145.03%
AVXL Anavex Life Sciences Corp.	$606M	$170,000 0.0% of portfolio	19,879	Q4 2024 Reduced 0.01%
AVTE Aerovate Therapeutics, Inc.	$65.5M	$148,000 0.0% of portfolio	59,097	Q4 2024 Added 86.76%
ENTA Enanta Pharmaceuticals Inc	$120M	$140,000 0.0% of portfolio	25,503	Q1 2025 Reduced 19.67%
VERV Verve Therapeutics, Inc.	$254M	$138,000 0.0% of portfolio	30,315	Q1 2025 Reduced 31.32%
SAGE Sage Therapeutics, Inc.	$404M	$128,000 0.0% of portfolio	16,162	Q1 2025 New
REPL Replimune Group, Inc.	$417M	$120,000 0.0% of portfolio	12,323	Q1 2025 Reduced 0.02%
XNCR Xencor Inc	$449M	$115,000 0.0% of portfolio	10,828	Q1 2025 Added 4.04%
ABCL Ab Cellera Biologics Inc.	$567M	$106,000 0.0% of portfolio	47,934	Q1 2025 Reduced 6.83%
RPTX Repare Therapeutics Inc.	$55.4M	$104,000 0.0% of portfolio	105,233	Q1 2025 Reduced 0.01%
BCRX Biocryst Pharmaceuticals Inc	$1.87B	$100,000 0.0% of portfolio	13,335	Q1 2025 Reduced 3.26%
NVAX Novavax Inc	$556M	$91,000 0.0% of portfolio	14,269	Q1 2025 Reduced 0.32%
RCUS Arcus Biosciences, Inc.	$621M	$85,000 0.0% of portfolio	10,899	Q1 2025 New
HLVX Hille Vax, Inc.	$65.5M	$85,000 0.0% of portfolio	58,834	Q1 2025 Added 64.51%
RLAY Relay Therapeutics, Inc.	$344M	$83,000 0.0% of portfolio	31,778	Q1 2025 New
TSVT 2seventy Bio, Inc.	$189M	$77,000 0.0% of portfolio	15,653	Q1 2025 New
VIR Vir Biotechnology, Inc.	$598M	$77,000 0.0% of portfolio	11,974	Q1 2025 Added 19.31%
NKTX Nkarta, Inc.	$82.7M	$68,000 0.0% of portfolio	37,386	Q1 2025 New
RXRX Recursion Pharmaceuticals, Inc.	$740M	$62,000 0.0% of portfolio	11,837	Q1 2025 Added 2.18%
DMAC Dia Medica Therapeutics Inc.	$107M	$58,000 0.0% of portfolio	15,560	Q4 2024 New
HRTX Heron Therapeutics, Inc.	$226M	$57,000 0.0% of portfolio	26,101	Q1 2025 New
GERN Geron Corp	$506M	$52,000 0.0% of portfolio	32,961	Q1 2025 Reduced 0.56%
LXRX Lexicon Pharmaceuticals, Inc.	$123M	$46,000 0.0% of portfolio	100,000	Q1 2025 Added 42.86%
IBRX Immunity Bio, Inc.	$1.06B	$42,000 0.0% of portfolio	14,224	Q1 2025 Added 11.81%
PRQR Pro Qr Therapeutics N.V.	$121M	$39,000 0.0% of portfolio	30,000	Q4 2023 New
ZNTL Zentalis Pharmaceuticals, Inc.	$69M	$37,000 0.0% of portfolio	23,459	Q1 2025 New
TCRX T Scan Therapeutics, Inc.	$27.3M	$34,000 0.0% of portfolio	24,992	Q1 2025 New
CCCC C4 Therapeutics, Inc.	$67.5M	$33,000 0.0% of portfolio	20,800	Q1 2025 Reduced 14.93%
AKBA Akebia Therapeutics, Inc.	$526M	$24,000 0.0% of portfolio	12,584	Q1 2025 New
LEXX Lexaria Bioscience Corp.	$5.77M	$23,000 0.0% of portfolio	14,033	Q1 2025 Added 0.24%
ONCY Oncolytics Biotech Inc	$23.1M	$21,000 0.0% of portfolio	39,168	Q1 2025 Reduced 0.16%
RAPT Rapt Therapeutics, Inc.	$26.4M	$18,000 0.0% of portfolio	15,016	Q1 2025 New
INZY Inozyme Pharma, Inc.	$159M	$9,000 0.0% of portfolio	10,297	Q1 2025 New
IPA Immuno Precise Antibodies Ltd.	$11.9M	$8,000 0.0% of portfolio	22,057	Q1 2025 Reduced 37.53%
VXRT Vaxart, Inc.	$56.9M	$6,000 0.0% of portfolio	15,125	Q1 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.